The squalene‐2,3‐epoxide cyclase as a model for the development of new drugs

Abstract

The 2,3‐oxido squalene (SO) cyclases represent a group of enzymes which convert SO into polycyclic triterpenoids such as lanosterol, cycloartenol, cucurbitadienol and β‐amyrin. Taking into account the postulated model of the enzymatic cyclization of SO, we have investigated the possibility of designing compounds that would be selective and potent inhibitors of SO cyclases. Due to the fundamental role of sterols in animal, higher plant and fungal tissues, these inhibitors might behave as very selective (ipocholesterolemic, antifungal or phytotoxic) drugs.Our first approach was the synthesis and biological evaluation of 2‐aza‐2,3‐dihydrosqualene and its derivatives which, being protonated at physiological pH, would present some similarities to the C‐2 carbon ion generated by the opening of the oxirane ring of SO. Microsomes from different sources (germinated pea cotyledons, maize seedlings, rat liver and yeasts) were utilized to determine the inhibition values (I₅₀: concentration of inhibitor producing 50% inhibition at a given substrate concentration).From the results obtained so far we conclude that 2‐aza‐2‐dihydrosqualene and its derivatives strongly inhibited the cyclases, the site of the enzyme responsible for binding to the inhibitor is quite sensitive to the steric hindrance, and the degree of the inhibitory activity is greater in higher plants than in rat liver or fungi.